Global Pediatric Vaccine Market 2014-2018

Global Pediatric Vaccine Market 2014-2018

Category : Healthcare
Published On : October  2014
Pages : 85



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com
About Pediatric Vaccines
Pediatric vaccines are used for the immunization of children and adolescents against various infectious diseases, such as diphtheria, influenza, hepatitis, pneumococcal diseases, and meningococcal diseases. According to the US FDA, pediatric age ranges are classified as newborn, infant, child, and adolescent, ranging from birth to 21 years. However, the EMA classifies pediatric age range from birth to 18 years.
TechNavio's analysts forecast the Global Pediatric Vaccine market to grow at a CAGR of 10.25 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Pediatric Vaccine market for the period 2014-2018. To calculate the market size, the report considers revenue generated through the sales of various approved vaccines. 
TechNavio's report, the Global Pediatric Vaccine Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Pediatric Vaccine market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• APAC
• EMEA        
Key Vendors
• GlaxoSmithKline
• Merck
• Pfizer
• Sanofi 
Other Prominent Vendors
 
• AstraZeneca
• Bavarian Nordic
• Baxter
• Bharat Biotech
• Bharat Immunologicals and Biologicals 
• bioCSL
• Bio Med
• Crucell
• Dynavax Technologies
• Indian Immunologicals
• Janssen 
• Kaketsuken
• LG Life Sciences
• Lupin
• Mitsubishi Tanabe Pharma
• Novartis
• Nuron 
• Panacea Biotec
• Serum Institute of India
• Shenzhen Kangtai Biological Products 
• Sinovac Biotech
• S K Chemicals
• Takeda Pharmaceutical 
• Valeant Pharmaceuticals
• Zydus Cadila
 

Market Driver
• Inclusion in National Immunization Schedule
• For a full, detailed list, view our report
Market Challenge
• Inadequate Vaccine Coverage
• For a full, detailed list, view our report
Market Trend
• Increase in Strategic Alliances
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Route of Administration
07.1 Oral
07.2 Parenteral
08. Market Segmentation by Product Type
08.1 Polysaccharide Vaccines
08.2 Conjugate Vaccines
09. Geographical Segmentation
09.1 Pediatric Vaccine Market in Americas
09.1.1 Market Size and Forecast
09.1.2 Pediatric Vaccine Market in US
09.1.3 Pediatric Vaccine Market in Latin America
09.2 Pediatric Vaccine Market in EMEA
09.2.1 Market Size and Forecast
09.2.2 Pediatric Vaccine Market in Europe
09.3 Pediatric Vaccine Market in APAC
09.3.1 Market Size and Forecast
09.3.2 Pediatric Vaccine Market in China
09.3.3 Pediatric Vaccine Market in India
09.3.4 Pediatric Vaccine Market in Japan
10. Key Leading Countries
10.1 US
10.2 China
10.3 India
10.4 Japan
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Market Share Analysis 2013
18.2.1 GlaxoSmithKline
18.2.2 Sanofi
18.2.3 Pfizer
18.2.4 Merck
18.3 Other Prominent Vendors
19. Key Vendor Analysis
19.1 GlaxoSmithKline
19.1.1 Key Facts
19.1.2 Business Overview
19.1.3 Business Segmentation
19.1.4 Business Segmentation by Revenue 2012 and 2013
19.1.5 Sales by Geography
19.1.6 Pipeline Products
19.1.7 Business Strategy
19.1.8 Key Information
19.1.9 SWOT Analysis
19.2 Merck & Co. Inc.
19.2.1 Key Facts
19.2.2 Business Overview
19.2.3 Business Segmentation by Revenue 2013
19.2.4 Business Segmentation by Revenue 2012 and 2013
19.2.5 Sales by Geography
19.2.6 Business Strategy
19.2.7 Key Developments
19.2.8 SWOT Analysis
19.3 Pfizer Inc.
19.3.1 Key Facts
19.3.2 Business Description
19.3.3 Business Segmentation
19.3.4 Revenue by Business Segmentation
19.3.5 Revenue Comparison 2012 and 2013
19.3.6 Sales by Geography
19.3.7 Business Strategy
19.3.8 Key Developments
19.3.9 SWOT Analysis
19.4 Sanofi
19.4.1 Key Facts
19.4.2 Business Overview
19.4.3 Business Segmentation by Revenue 2013
19.4.4 Business Segmentation by Revenue 2012 and 2013
19.4.5 Geographical Segmentation by Revenue 2013
19.4.6 Business Strategy
19.4.7 Key Developments
19.4.8 SWOT Analysis
20. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Pediatric Vaccine Market 2013-2018 (US$ billion)
Exhibit 3: Global Pediatric Vaccine Market Segmentation by Route of Administration
Exhibit 4: Global Pediatric Vaccine Market by Route of Administration 2013
Exhibit 5: Global Pediatric Vaccine Market Segmentation by Product Type
Exhibit 6: Global Pediatric Vaccine Market Segmentation by Product Type 2013
Exhibit 7: Global Pediatric Vaccine Market by Geographical Segmentation 2013
Exhibit 8: Global Pediatric Vaccine Market by Region/Country 2013
Exhibit 9: Pediatric Vaccine Market in Americas by Region/Country 2013
Exhibit 10: Pediatric Vaccine Market in Americas by Region/Country 2018
Exhibit 11: Pediatric Vaccine Market in Americas 2013-2018 (US$ billion)
Exhibit 12: Pediatric Vaccine Market in the US 2013-2018 (US$ billion)
Exhibit 13: Pediatric Vaccine Market in Latin America 2013-2018 (US$ billion)
Exhibit 14: Pediatric Vaccine Market in EMEA by Region 2013
Exhibit 15: Pediatric Vaccine Market in EMEA by Region 2018
Exhibit 16: Pediatric Vaccine Market in EMEA 2013-2018 (US$ billion)
Exhibit 17: Pediatric Vaccine Market in Europe 2013-2018 (US$ billion)
Exhibit 18: Pediatric Vaccine Market in APAC by Region 2013
Exhibit 19: Pediatric Vaccine Market in APAC by Region 2018
Exhibit 20: Pediatric Vaccine Market in APAC 2013-2018 (US$ billion)
Exhibit 21: Pediatric Vaccine Market in China 2013-2018 (US$ billion)
Exhibit 22: Pediatric Vaccine Market in India 2013-2018 (US$ billion)
Exhibit 23: Pediatric Vaccine Market in Japan 2013-2018 (US$ billion)
Exhibit 24: Comparison of Global Vaccine Market to Global Pediatric Vaccine Market 2013
Exhibit 25: Global Pediatric Vaccine Market Share Analysis 2013
Exhibit 26: GlaxoSmithKline's Revenue 2013
Exhibit 27: Sanofi's Revenue 2013
Exhibit 28: Pfizer's Revenue 2013
Exhibit 29: Merck's Revenue 2013
Exhibit 30: GlaxoSmithKline: Business Segmentation 2013
Exhibit 31: GlaxoSmithKline: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 32: GlaxoSmithKline: Sales by Geography 2013
Exhibit 33: GlaxoSmithKline: Pipeline Products 2013
Exhibit 34: Merck & Co. Inc.: Business Segmentation by Revenue 2013
Exhibit 35: Merck & Co. Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 36: Merck & Co. Inc.: Sales by Geography 2013
Exhibit 37: Pfizer Inc.: Business Segmentation
Exhibit 38: Pfizer Inc.: Revenue by Business Segmentation 2013
Exhibit 39: Pfizer Inc.: Revenue by Business Segmentation 2012 and 2013
Exhibit 40: Pfizer Inc.: Revenue by Geography 2013
Exhibit 41: Sanofi: Business Segmentation by Revenue 2013
Exhibit 42: Sanofi: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 43: Sanofi: Geographical Segmentation by Revenue 2013

Enquiry Before Buy